# Glucomen Day Cascade CGM System 21-Day Wear Study

> **NCT05460260** · — · COMPLETED · sponsor: **WaveForm Technologies Inc.** · enrollment: 10 (actual)

## Conditions studied

- Efficacy of a 21-Day Wear Period for the Cascade CGM

## Interventions

- **DEVICE:** Cascade CGM

## Key facts

- **NCT ID:** NCT05460260
- **Lead sponsor:** WaveForm Technologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-12
- **Primary completion:** 2020-09-27
- **Final completion:** 2020-11-15
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05460260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05460260, "Glucomen Day Cascade CGM System 21-Day Wear Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05460260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
